Cargando…

Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study

PURPOSE: The use of carbapenem before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy at a tertiary care center in Lebanon was evaluated. METHODS: A retrospective, observational chart review was performed on all hospitalized pediatric and adult patients who r...

Descripción completa

Detalles Bibliográficos
Autores principales: El Masri, Mira, Haddad, Nisrine, Saad, Therese, Rizk, Nesrine A., Zakhour, Ramia, Kanj, Souha S., Zeenny, Rony M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990088/
https://www.ncbi.nlm.nih.gov/pubmed/35402313
http://dx.doi.org/10.3389/fcimb.2022.729491
_version_ 1784683311807856640
author El Masri, Mira
Haddad, Nisrine
Saad, Therese
Rizk, Nesrine A.
Zakhour, Ramia
Kanj, Souha S.
Zeenny, Rony M.
author_facet El Masri, Mira
Haddad, Nisrine
Saad, Therese
Rizk, Nesrine A.
Zakhour, Ramia
Kanj, Souha S.
Zeenny, Rony M.
author_sort El Masri, Mira
collection PubMed
description PURPOSE: The use of carbapenem before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy at a tertiary care center in Lebanon was evaluated. METHODS: A retrospective, observational chart review was performed on all hospitalized pediatric and adult patients who received carbapenem therapy during January 2019 and January 2020. Patients who started their regimen before January or received carbapenems for less than 24 hours were excluded. Primary outcomes included the appropriateness of physician prescribing patterns and pharmacists’ interventions, as well as appropriateness and response rates of the latter. Secondary outcomes included the carbapenem defined daily dose (DDD) and days of therapy (DOT). Descriptive statistics were used in the analysis and a p-value < 0.05 was considered to be statistically significant. RESULTS: A total of 157 and 150 patients charts were reviewed in January 2019 and January 2020, respectively. There was no difference in baseline characteristics except for inpatient services and rates of isolated multidrug-resistant organisms. When comparing the two timelines, the appropriateness of physicians’ prescribing patterns increased in terms of empirical therapy, targeted therapy, and duration of therapy but the results were not statistically significant. Pharmacists’ interventions significantly increased with regards to the duration of therapy (p= <0.001), dose adjustment (p<0.001), de-escalation to a narrower spectrum antibiotic (p=0.007), and use of extended infusion (p=0.042). The DDD and DOT were higher for ertapenem and lower for anti-pseudomonal carbapenems in January 2020. CONCLUSION: The carbapenem-sparing strategy adopted by the antimicrobial stewardship program contributed to an increase in the number of interventions made by pharmacists on carbapenem therapy, including their appropriateness, and response rate. Despite an improvement in the physician-prescribing patterns, more awareness and education may be needed to achieve a better impact.
format Online
Article
Text
id pubmed-8990088
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89900882022-04-09 Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study El Masri, Mira Haddad, Nisrine Saad, Therese Rizk, Nesrine A. Zakhour, Ramia Kanj, Souha S. Zeenny, Rony M. Front Cell Infect Microbiol Cellular and Infection Microbiology PURPOSE: The use of carbapenem before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy at a tertiary care center in Lebanon was evaluated. METHODS: A retrospective, observational chart review was performed on all hospitalized pediatric and adult patients who received carbapenem therapy during January 2019 and January 2020. Patients who started their regimen before January or received carbapenems for less than 24 hours were excluded. Primary outcomes included the appropriateness of physician prescribing patterns and pharmacists’ interventions, as well as appropriateness and response rates of the latter. Secondary outcomes included the carbapenem defined daily dose (DDD) and days of therapy (DOT). Descriptive statistics were used in the analysis and a p-value < 0.05 was considered to be statistically significant. RESULTS: A total of 157 and 150 patients charts were reviewed in January 2019 and January 2020, respectively. There was no difference in baseline characteristics except for inpatient services and rates of isolated multidrug-resistant organisms. When comparing the two timelines, the appropriateness of physicians’ prescribing patterns increased in terms of empirical therapy, targeted therapy, and duration of therapy but the results were not statistically significant. Pharmacists’ interventions significantly increased with regards to the duration of therapy (p= <0.001), dose adjustment (p<0.001), de-escalation to a narrower spectrum antibiotic (p=0.007), and use of extended infusion (p=0.042). The DDD and DOT were higher for ertapenem and lower for anti-pseudomonal carbapenems in January 2020. CONCLUSION: The carbapenem-sparing strategy adopted by the antimicrobial stewardship program contributed to an increase in the number of interventions made by pharmacists on carbapenem therapy, including their appropriateness, and response rate. Despite an improvement in the physician-prescribing patterns, more awareness and education may be needed to achieve a better impact. Frontiers Media S.A. 2022-03-25 /pmc/articles/PMC8990088/ /pubmed/35402313 http://dx.doi.org/10.3389/fcimb.2022.729491 Text en Copyright © 2022 El Masri, Haddad, Saad, Rizk, Zakhour, Kanj and Zeenny https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
El Masri, Mira
Haddad, Nisrine
Saad, Therese
Rizk, Nesrine A.
Zakhour, Ramia
Kanj, Souha S.
Zeenny, Rony M.
Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title_full Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title_fullStr Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title_full_unstemmed Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title_short Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
title_sort evaluation of carbapenem use before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy in a lebanese tertiary hospital: a retrospective study
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990088/
https://www.ncbi.nlm.nih.gov/pubmed/35402313
http://dx.doi.org/10.3389/fcimb.2022.729491
work_keys_str_mv AT elmasrimira evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT haddadnisrine evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT saadtherese evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT rizknesrinea evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT zakhourramia evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT kanjsouhas evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy
AT zeennyronym evaluationofcarbapenemusebeforeandafterimplementationofanantimicrobialstewardshipledcarbapenemsparingstrategyinalebanesetertiaryhospitalaretrospectivestudy